After years and a growing amount of citizen petitions from members of the public, FDA is holding a "virtual public meeting" on February 9, 2023 to discuss their ongoing relationship with AAFCO. As we know, AAFCO is a collection of public regulators who FDA refers to as their "regulatory partners". These public regulators are creating regulations and law in private, and those regulations are specifically designed for products in FDA regulatory jurisdiction. In addition to holding the public meeting, FDA is accepting electronic or written comments through March 9, 2023. To electronically submit comments to the docket, visit regulations.gov and type “FDA-2022-N-3122” in the search box. While calendar records reveal FDA-CVM employees found an abundance of time to personally meet with lobbying groups over the years, many citizens have reported that FDA-CVM has completely ignored dozens (or possibly hundreds) of their questions over the past few years. For those that have...